How will the Celgene funding process including IME change, and what is the timing of the changes?
Until further notice, there will not be any changes to Celgene’s funding process, and funding requests may continue to be submitted via the current Celgene process.
During this transition period, BMS and Celgene will jointly review requests as a team to avoid duplication of funding.
If my organization has received funding from both Celgene and BMS in the past, should I continue to submit requests to both organizations?
You may submit funding requests to Celgene or BMS, but only one request per activity will be accepted. Do not submit a request for the same activity to both Celgene and BMS. During this transition period, we will jointly review requests as a team to avoid duplication of funding.
What happens if I have current requests pending with both Celgene and BMS?
At this time, no further action is required on your part. During the transition period, both the Celgene and BMS Corporate Giving teams will jointly review requests to avoid potential duplication of funding.
How will the review timelines for Corporate Giving requests including IME be impacted during the transition period?
Until further notice, funding requests submitted to Celgene will continue to follow the current process. During the transition period, there may be delays in processing your request. We thank you in advance for your patience.
Will the review criteria change?
No. Funding requests submitted to Celgene will be reviewed under the same criteria until further notice and the transition is complete.
Will there be changes in the types/scope of requests supported?
Through the transition period, there will not be any changes to the types or scope of requests supported by the Celgene funding process. During the first quarter of 2020, Celgene and BMS plan to unify funding processes. Updates will be provided accordingly.
Will the therapeutic areas of interest for Celgene funding support change?
No, Celgene will continue to support requests in the current therapeutic areas of interest that are posted on our website . During the first quarter of 2020, Celgene and BMS plan to unify funding processes. Updates will be provided accordingly.
Who do I contact if I have questions about the transition process?
Donations, Sponsorships, Exhibits, or Corporate Memberships:
—For General questions or Status of specific request, please email: firstname.lastname@example.org
–For Technical support, please access Celgene’s funding page: http://www.toutou63.com/responsibility/funding/.
From the ‘Types of Support’ section, select the appropriate funding type. Click on “Click Here if Applying,” then click “Continue.” Click “Need Support” (at bottom of page), then click “Still have a question” (at bottom of page), complete ‘Support Request’ form and click “Submit.”